Suppr超能文献

β-抑制蛋白/衔接蛋白-2相互作用在G蛋白偶联受体内化中的作用:β2-衔接蛋白中β-抑制蛋白结合位点的鉴定

beta-Arrestin/AP-2 interaction in G protein-coupled receptor internalization: identification of a beta-arrestin binging site in beta 2-adaptin.

作者信息

Laporte Stephane A, Miller William E, Kim Kyeong-Man, Caron Marc G

机构信息

Howard Hughes Medical Institute Laboratories, the Department of Cell Biology, and the Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.

出版信息

J Biol Chem. 2002 Mar 15;277(11):9247-54. doi: 10.1074/jbc.M108490200. Epub 2002 Jan 2.

Abstract

beta-Arrestins, proteins involved in the turn-off of G protein-coupled receptor (GPCR) activation, bind to the beta(2)-adaptin subunit of the clathrin adaptor AP-2. The interaction of beta(2)-adaptin with beta-arrestin involves critical arginine residues in the C-terminal domain of beta-arrestin and plays an important role in initiating clathrin-mediated endocytosis of the beta(2)-adrenergic receptor (beta(2)AR) (Laporte, S. A., Oakley, R. H., Holt, J. A., Barak, L. S., and Caron, M. G. (2000) J. Biol. Chem. 275, 23120--23126). However, the beta-arrestin-binding site in beta(2)-adaptin has not been identified, and little is known about the role of beta-arrestin/AP-2 interaction in the endocytosis of other GPCRs. Using in vitro binding assays, we have identified two glutamate residues (Glu-849 and Glu-902) in beta(2)-adaptin that are important in beta-arrestin binding. These residues are located in the platform subdomain of the C terminus of beta(2)-adaptin, where accessory/adapter endocytic proteins for other classes of receptors interact, distinct from the main site where clathrin interacts. The functional significance of the beta-arrestin/AP-2/clathrin complex in the endocytosis of GPCRs such as the beta(2)AR and vasopressin type II receptor was evaluated using mutant constructs of the beta(2)-adaptin C terminus containing either the clathrin and the beta-arrestin binding domains or the beta-arrestin-binding domain alone. When expressed in human embryonic kidney 293 cells, both constructs acted as dominant negatives inhibiting the agonist-induced internalization of the beta(2)AR and the vasopressin type II receptor. In addition, although the beta(2)-adaptin construct containing both the clathrin and beta-arrestin binding domains was able to block the endocytosis of transferrin receptors, a beta(2)-adaptin construct capable of associating with beta-arrestin but lacking its high affinity clathrin interaction did not interfere with transferrin receptor endocytosis. These results suggest that the interaction of beta-arrestin with beta(2)-adaptin represents a selective endocytic trigger for several members of the GPCR family.

摘要

β抑制蛋白是参与关闭G蛋白偶联受体(GPCR)激活的蛋白质,它与网格蛋白衔接蛋白AP-2的β(2)-衔接蛋白亚基结合。β(2)-衔接蛋白与β抑制蛋白的相互作用涉及β抑制蛋白C末端结构域中的关键精氨酸残基,并且在启动β(2)-肾上腺素能受体(β(2)AR)的网格蛋白介导的内吞作用中起重要作用(拉波特,S.A.,奥克利,R.H.,霍尔特,J.A.,巴拉克,L.S.,和卡隆,M.G.(2000年)《生物化学杂志》275,23120 - 23126)。然而,β(2)-衔接蛋白中的β抑制蛋白结合位点尚未确定,并且对于β抑制蛋白/AP-2相互作用在其他GPCR内吞作用中的作用知之甚少。通过体外结合试验,我们在β(2)-衔接蛋白中鉴定出两个谷氨酸残基(Glu-849和Glu-902),它们在β抑制蛋白结合中很重要。这些残基位于β(2)-衔接蛋白C末端的平台亚结构域中,其他类受体的辅助/衔接内吞蛋白在此相互作用,这与网格蛋白相互作用的主要位点不同。使用含有网格蛋白和β抑制蛋白结合结构域或仅含β抑制蛋白结合结构域的β(2)-衔接蛋白C末端的突变构建体,评估了β抑制蛋白/AP-2/网格蛋白复合物在β(2)AR和血管加压素II型受体等GPCR内吞作用中的功能意义。当在人胚肾293细胞中表达时,这两种构建体均作为显性负性物,抑制激动剂诱导的β(2)AR和血管加压素II型受体的内化。此外,虽然含有网格蛋白和β抑制蛋白结合结构域的β(2)-衔接蛋白构建体能够阻断转铁蛋白受体的内吞作用,但能够与β抑制蛋白结合但缺乏其高亲和力网格蛋白相互作用的β(2)-衔接蛋白构建体并不干扰转铁蛋白受体的内吞作用。这些结果表明,β抑制蛋白与β(2)-衔接蛋白的相互作用代表了GPCR家族几个成员的选择性内吞触发因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验